Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired VitalHealth, a leading provider of cloud-based population health management solutions for the delivery of personalized care outside of the hospital, for example, in regional care networks.

Royal Philips (NYSE: PHG, AEX: PHIA), a leader in health technology, is pleased to be associated with the government's recently announced £4.7 billion Industrial Strategy Challenge Fund. Working with public bodies, industry colleagues, the Office of Life Sciences and the Department of Business, Energy and Industrial Strategy, Philips will contribute to the development of artificial intelligence (AI) based and digital diagnostic solutions at scale.

Rockstart Digital Health Accelerator provides an unparalleled access to the healthcare ecosystem, capital, coaching and investors for entrepreneurs who are looking to change the way things are done in healthcare. It will help you better understand product design, market fit and business models by enabling you to directly work with patients, professionals and other stakeholders.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired US-based start-up company Analytical Informatics, Inc., complementing its own innovation initiatives to expand its current offerings and accelerate the roadmap for Philips Radiology Solutions. Analytical Informatics' products and capabilities, which include vendor-agnostic, advanced workflow tools and applications,

Vertical is not your typical startup accelerator, it does not cover startups pitch training, vision/mission or product-market-fit. VERTICAL expects entrepreneurs to have the fundamentals of their ventures in place. Vertical team combines the tenacity of start-up fervour with the experienced corporate world, the accelerator collaborates to create industry-first developments and pave the way forward.

Boehringer Ingelheim has announced the launch of opnME.com, a new platform offering free and open access to selected pre-clinical molecules for non-clinical investigation to scientists worldwide. Through opnME.com, molecules for some of the most relevant targets in biomedical research are shared, thereby creating possibilities for further independent and collaborative discovery as well as the identification of novel treatment approaches for patients.

The Bundesnetzagentur prohibits the sale of children's watches that have an "eavesdropping" function and has already taken action against several offers on the internet. "Parents can use these children's watches to listen in to the child's surroundings without detection via an app. The watches are regarded as unauthorised transmitting equipment," said Jochen Homann, Bundesnetzagentur President. "Our investigations found, for example, that parents were using them to eavesdrop on teachers in lessons."